Skip to content

SION SION Preferred Stock Par Value Per Share

Preferred Stock Par Value Per Share at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0.010.0%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$0.010.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's preferred stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's preferred stock par value per share?
SION (SION) reported preferred stock par value per share of $0.00 in Q1 2026.
How has SION's preferred stock par value per share changed year-over-year?
SION's preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
What does preferred stock par value per share mean?
The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.